Cyclic Lactamase Substrate for Signal Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting lactamase activity are limited by low turnover rates and environmental effects, leading to challenges in detecting low concentrations of targets and intracellular events, particularly in assays where sensitivity and specificity are crucial.
Innovation Solution
A cyclic substrate is used, comprising a β-galactosidase fragment linked on opposite sides of a lactamase substrate to form a ring compound that is cleaved by lactamase, resulting in linearization and increased affinity for enzyme acceptor fragments, providing an amplified fluorescent or chemiluminescent signal with minimal background.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional lactamase substrates are used for detection, then the assay can be performed with standard protocols, but the sensitivity is insufficient for detecting low concentrations of targets and intracellular events
Solution Approach 1:
The substrate is divided into two fragments (first and second fragments) that are separated by a cleavable linkage. The first fragment contains the β-galactosidase binding domain, while the second fragment contains the detectable label. When lactamase cleaves the linkage, the fragments separate and the second fragment becomes detectable, providing amplified signal for low-concentration targets.
Solution Approach 2:
A cleavable linkage acts as an intermediary between the substrate binding domain and the detectable label. This linkage is specifically designed to be cleaved by lactamase, serving as a mediator that translates enzyme activity into a detectable signal through fragment separation.
2Ease of operation
If lactamase is used as an enzyme label, then it is small and does not interfere with fused protein function, but it has a relatively low turnover rate compared to β-galactosidase
Solution Approach 1:
The substrate is segmented into fragments that separate upon cleavage, allowing the detectable label to be released and accumulate in solution. This segmentation enables signal amplification that compensates for lactamase's lower turnover rate, maintaining productivity while preserving the advantage of using a small enzyme label.
Solution Approach 2:
The invention changes the detection parameter from measuring substrate consumption (which is limited by turnover rate) to measuring product accumulation (fragment separation and label release). This parameter change allows detection of low-concentration targets even with slower-turnover enzymes like lactamase.
3Measurement precision
If enzyme labels are used to detect intracellular events, then single events can be translated into multiple events through substrate turnover, but environmental effects and partial inhibitors limit the amplification capability
Solution Approach 1:
The cleavable linkage serves as a protected intermediary that shields the detectable label from environmental effects until lactamase cleavage occurs. This mediator approach allows the label to remain hidden and protected during storage and handling, then becomes active only when specifically released by enzyme-catalyzed cleavage, reducing environmental sensitivity.
Solution Approach 2:
The substrate is pre-assembled with the detectable label attached via the cleavable linkage in a stable, non-fluorescent state. This preliminary assembly allows the labeled substrate to be stored and handled without degradation or background signal, then activated in situ by lactamase cleavage when needed for detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the sensitivity and specificity of lactamase detection, allowing for the investigation of biological processes that might otherwise go undetected, with a significant reduction in background noise and improved assay sensitivity.
Implementation Method 1
a cyclic substrate comprising a β-galactosidase fragment linked on opposite sides of a lactamase substrate to form a ring compound that is cleaved by lactamase, resulting in linearization
Implementation Method 2
linearization results in increased affinity for enzyme acceptor fragments
Implementation Method 3
providing an amplified fluorescent or chemiluminescent signal
Implementation Method 4
providing an amplified fluorescent or chemiluminescent signal
Data Source
AI summary
An amplifiable β-lactamase substrate is provided comprising an enzyme donor fragment of β-galactosidase linked to form a ring to a β-lactam ring that is a substrate for lactamase and upon opening of the β-lactam ring the enzyme donor fragment becomes linearized. The cyclic substrate only weakly binds to the enzyme acceptor fragment of β-galactosidase. The substrate finds application for the sensitive detection of β-lactamase for direct detection of the enzyme or when the enzyme is used as a label.